The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses

Danrui Cui1,2,3, Ruirui Qu1,2,4, Dian Liu1,2,4

  • 1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Insights

The tumor suppressor p53 and mTOR pathway are key in cancer. This review explores their complex interplay, crucial for balancing cellular stress responses and survival.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • The tumor suppressor p53 and the mammalian target of rapamycin (mTOR) pathway are critical regulators of cellular processes.
  • Dysregulation of p53 and mTOR signaling is frequently observed in human cancers.
  • The interplay between p53 and mTOR governs cellular responses to stress, proliferation, and survival.

Purpose of the Study:

  • To review the regulatory roles of the p53 and mTOR pathways in cellular stress responses and cancer.
  • To elucidate the mechanisms by which p53 influences mTOR signaling and vice versa.
  • To discuss the implications of their coordinated regulation for cancer therapy.

Main Methods:

  • Literature review of studies investigating p53 and mTOR pathways.
  • Analysis of transcriptional and non-transcriptional regulation between p53 and mTOR.
  • Discussion of the role of mTOR in modulating p53 activity.

Main Results:

  • p53 activation by cellular stresses (DNA damage, hypoxia) influences mTOR activity.
  • mTOR pathway signaling impacts p53 stability and function.
  • Complex feedback loops exist between p53 and mTOR, affecting cell fate decisions.

Conclusions:

  • The intricate relationship between p53 and mTOR is central to cancer development and progression.
  • Targeting the coordinated regulation of p53 and mTOR pathways holds therapeutic potential for cancer treatment.
  • Further research is needed to fully understand and exploit these regulatory networks.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K